Advaxis, Inc.
$14.1 M
Secondary/Follow-On
Sole Book-Runner
Recro Pharma, Inc.
$34.5 M
IPO
Sole Book-Runner
Ceres, Inc.
$23 M
Secondary/Follow-On
Sole Book-Runner
Semler Scientific, Inc.
$10 M
IPO
Sole Book-Runner
GlobeImmune, Inc.
$7.5 M
Private Placement
NephroGenex, Inc.
$37.2 M
IPO
Sole Book-Runner
BioBlast Pharma Ltd.
$4.8 M
Private Placement
Biocept, Inc.
$19 M
IPO
Joint Book-Runner
SMTP, Inc.
$11.5 M
Secondary/Follow-On
Sole Book-Runner
CytRx Corporation
$86.3 M
Secondary/Follow-On
Kips Bay Medical, Inc.
$4.2 M
Secondary/Follow-On
Sole Book-Runner
Akers Biosciences, Inc.
$15 M
IPO
Sole Book-Runner